Extended Data Fig. 1: Markers used for applied therapeutic decisions.
From: Feasibility of multiomics tumor profiling for guiding treatment of melanoma
a, Markers (n = 54) used for treatment decision making in the adjuvant, SOC and beyond SOC cohorts. b, Markers (n = 12) used for treatment decision making in the adjuvant cohort. c, Individual measurements of markers for applied therapeutic decisions in the adjuvant setting. Markers (n = 12) and measurements (n = 50). d, Individual measurements of markers used for applied therapeutic decisions in the palliative SOC setting. Markers (n = 26) and measurements (n = 153). e, Individual measurements of markers used for applied therapeutic decisions in the beyond SOC setting. Markers (n = 44) and measurements (n = 196).
